XAGE (carmellcosmetics.com) Enterprise Value-to-Revenue Ratio

Official company branding of Carmell Therapeutics Corporation (XAGE)

Longevity Health Holdings (XAGE) management has built a resilient B2B regenerative aesthetics ecosystem with low partner churn. On GURU.Markets, this linear chart of the business value-to-annual revenue ratio visualizes the results of their strategy, where the mark serves as a key metric. High pricing power is driven by the Carmell Plasma Matrix platform, while ESG standards stimulate plastic reduction and energy efficiency across production facilities.

XAGE Carmell Therapeutics Corporation: Company Value to Revenue in the range 07/04/2022 - 11/20/2026

Financial and market metric breakdowns for Longevity Health Holdings Inc (XAGE)

- price and consensus price forecast:
Fundamental company valuation:Longevity Health Holdings XAGE
Core merchandise of Carmell Therapeutics Corporation

The development of the elite regenerative medicine and bio-aesthetics niche by Longevity Health (XAGE) requires capital-intensive investments in unique tissue restoration platforms. An analysis of the EV/Sales ratio allows for an assessment of the business's market value, accounting for net debt relative to generated revenue while excluding the influence of the financing structure. The dynamics of this indicator help investors objectively determine the company's organic growth phase, separating real fundamental value from speculative volatility.

Competitor analysis for Longevity Health Holdings

Enterprise Value-to-Revenue Multiple hcahealthcare.com|THC: EV/Sales Multiple|FMS - Total Company Value-to-Revenue Ratio|Company Value to Revenue SOLV|Encompass (EHC) - Total Company Value-to-Revenue Ratio|Enterprise Value-to-Revenue Ratio Universal Health Services, Inc. (UHS)|DaVita Inc. - Company Value to Revenue Ratio|Enterprise Value-to-Revenue Ratio RadNet Corp RDNT|EV/Sales Multiple Option Care OPCH|Surgery Partners Inc - EV/Sales Multiple|PINC (Premier Corp) - Company Value to Revenue Ratio|nationalvision.com (EYE) - Enterprise Value-to-Revenue Ratio|Company Value to Revenue Progyny|Company Value to Revenue ARDT|EV/Sales Multiple Select Medical Corporation|Company Value to Revenue ASTH (Astrana Health)|Company Value to Revenue Pediatrix MD|U.S. Physical Therapy - Company Value to Revenue|Business Value to Revenue PNTG|Organogenesis - EV/Sales Multiple|NUTX (Nutex Health) - Company Value to Revenue Ratio|AUNA (Auna) - Company Value to Revenue|Enterprise Value to Sales Volume SBC (SBC Medical Group Holdings)|Enterprise Value-to-Revenue Ratio Evolus, Inc.|Community Health Systems, Inc. (CYH) - Total Company Value-to-Revenue Ratio|Enterprise Value-to-Revenue Ratio Beauty Health (SKIN)|MediWound, Ltd. - Company Value to Revenue Ratio|EV/Sales Multiple BTMD (Biote)|Enterprise Value-to-Revenue Coefficient JYNT (The Joint Corp.)|DCGO - Enterprise Value-to-Revenue Ratio|PIII: Enterprise Value-to-Revenue Ratio|GANX: EV/Sales Multiple|Company Value to Revenue EUDA Health|BMGL (Basel Medical Group) - EV/Sales Multiple|CLGN - Enterprise Value-to-Sales Ratio|Enterprise Value-to-Revenue Ratio Cuprina Holdings (CUPR)|Total Company Value-to-Revenue Ratio Concord Medical Services|EV/Sales Multiple AMS (ashs.com)|MEDIROM Healthcare Group Inc. (MRM) - Enterprise Value-to-Revenue Multiple|ALBT: Company Value to Revenue|Business Value to Revenue DHAI (DIH Holding US Inc.)|NIVF (NewGenIvf Group Limited) - Company Value to Revenue|ATI Physical Therapy Inc. - Business Value to Revenue|CMAX (caremax.com) - EV/Sales Multiple|KDLY (Kindly MD Inc) - Enterprise Value-to-Revenue Coefficient|Enterprise Value-to-Revenue Ratio ModivCare Corp (MODV)|Total Company Value-to-Revenue Ratio Novo Integrated Sciences|SunLink Health Systems, Inc. - Company Value to Revenue|imacholdings.comm (BACK) - Enterprise Value-to-Revenue Multiple